Resources

Type of publications
Regions
Diseases
4760 results found
2025 ∙ Okoli, G. N. Soos, A. E. Etsell, K. Grossman Moon, A. Kimmel Supron, H. Grewal, A. Neilson, C. J. Richardson, C. Harper, D. M.
Socioeconomic and Health-Related Characteristics Associated with Initiation and Completion of Human Papillomavirus Vaccination among Males in the United States: An In-Depth Systematic Review and Meta-Analysis
Americas United States of America Adolescents Adults Human papillomavirus (HPV) Coverage
Rating:
Not applicable
2025 ∙ Cho, J. Y. Lee, H. Wannaadisai, W. Vietri, J. Chaiyakunapruk, N.
Systematic literature review of cost-effectiveness analyses of adult 15- and 20-valent pneumococcal vaccines
Adults Older adults Pneumococcal disease Economic aspects
Rating:
Not applicable
2025 ∙ Deese, J. Schaible, K. Massierer, D. Tingir, N. Fell, D. B. Atwell, J. E.
Systematic Literature Review of Maternal Antibodies in Human Milk Following Vaccination During Pregnancy or Lactation Tetanus, Pertussis, Influenza and COVID-19
Pregnant women Tetanus Pertussis Influenza COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Zarekar, M. Al-Shehabi, H. Dorner, R. Weishaar, H. Lennemann, T. El Bcheraoui, C. Bernasconi, A.
The impact of information and communication technology on immunisation and immunisation programmes in low-income and middle-income countries: a systematic review and meta-analysis
Children Low and Middle Income Countries Coverage Logistics
Rating:
Not applicable
2025 ∙ Jacobsen, I. M. Carlander, A. L. F. Aakilde, M. von Buchwald, C.
Trends in the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis following implementation of national HPV vaccination initiatives: a systematic review
Adolescents Adults Human papillomavirus (HPV) Efficacy/effectiveness Coverage
Rating:
Critically low
2025 ∙ Bardach, A. Brizuela, M. Berrueta, M. Ciapponi, A. Sambade, J. M. Ballivian, J. Ortega, V. Castellana, N. Comande, D. Parker, E. P. K. Kampmann, B. Stegelmann, K. Xiong, X. Stergachis, A. Munoz, F. M. Buekens, P. Mazzoni, A.
Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines
Pregnant women Newborn Children Adolescents Chikungunya Safety
Rating:
Not applicable
2025 ∙ Satyam, S. M. El-Tanani, M. Bairy, L. K. Rehman, A. Srivastava, A. Kenneth, J. M. Prem, S. M.
Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review
All age groups COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2025 ∙ Jafari, Z. Kolb, B. E. Aiken, S. Wilson, S.
Updates on Auditory Outcomes of COVID-19 and Vaccine Side Effects: An Umbrella Review
All age groups Pregnant women COVID-19 Safety
Rating:
Not applicable
2025 ∙ Pan, H. Yu, Y. Li, X. Wang, M. Wen, C. Dai, Q. Huang, L.
Vaccination and rheumatoid arthritis: an updated systematic review and meta-analysis of data from 25,949,597 participants
All age groups Safety
Rating:
Low
2025 ∙ Li, Y. Liu, Z. Zhou, L. Li, R.
Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis
Western Pacific China All age groups Economic aspects Acceptance
Rating:
Not applicable
Loading...